在消除小儿麻痹症的斗争中,赛诺菲从一开始就起着至关重要的作用,从供应大量剂量的OPV2来支持GPEI,并提供了超过140亿剂的口服疫苗。In preparation for the “end game,” the very last step of wild polio control, Sanofi has made significant investment over the past decade in its industrial capabilities and is now able to supply 50% of the IPV3 doses requested by UNICEF, an effort that is unique among all suppliers who support the initiative (Sanofi invested in a new IPV dedicated building to be able to support implementation of one dose of IPV in all countries and is now ready to supply for 2剂量按照新的WHO推荐)。Sanofi向联合国儿童基金会提供了最低的价格,以实施负担得起的计划。